Ablation Devices Market Report 2026

Ablation Devices Market Overview

• Ablation Devices market size has reached to $9.25 billion in 2025 • Expected to grow to $14.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Increasing Prevalence Of Chronic Diseases Drives Growth In Ablation Device Market • Market Trend: Advancing Atrial Fibrillation Treatment Through Next-Generation Pulsed Field Ablation Technologies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ablation Devices Market?

Ablation devices are medical instruments used to remove or destroy abnormal tissue growths or dysfunctional cells, such as tumors or cardiac arrhythmias, through various energy sources such as heat, cold, or radiofrequency. These devices are crucial in minimally invasive procedures to treat conditions ranging from cancer to heart rhythm disorders. The main product types of ablation devices are laser ablators, radiofrequency ablators, microwave ablators, ultrasound ablators, electric ablators, hydrothermal ablators, and cryoablators. Laser ablators are devices that use laser energy to remove material from a surface, often used in industrial applications for precise material removal or modification. The technology includes radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others, and its functions are automatic and robotic. It is used by various end-users, such as hospitals and clinics, ambulatory surgical centers, and others.

What Is The Ablation Devices Market Growth Forecast?

The ablation devices market size is expected to see strong growth in the next few years. It will grow to $14.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising demand for precision targeted tissue ablation technologies, growing adoption of robotic and automatic ablation systems, expansion of ablation applications across multiple therapeutic areas, increasing investment in outpatient and ambulatory surgical infrastructure, rising preference for minimally invasive procedures with faster recovery. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures across oncology and cardiology, rising utilization of radiofrequency and microwave ablation systems for targeted tissue destruction, growing preference for cryoablation and hydrothermal ablation in specialized clinical applications, expanding clinical use of laser and ultrasound ablation devices for precision therapeutic outcomes, increasing deployment of ablation technologies in ambulatory and outpatient surgical settings.

Global Ablation Devices Market Segmentation

1) By Product: Laser Ablators, Radiofrequency Ablators, Microwave Ablators, Ultrasound Ablators, Electric Ablators, Hydrothermal Ablators, Cryoablators 2) By Technology Type: Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation, Other Technology Types 3) By Function: Automatic, Robotic 4) By End-Users: Hospitals And Clinics, Ambulatory Surgical Centers, Others End-Users Subsegments: 1) By Laser Ablators: Diode Laser Systems, CO2 Laser Systems, Nd-YAG Laser Systems 2) By Radiofrequency Ablators: Monopolar Radiofrequency Ablators, Bipolar Radiofrequency Ablators 3) By Microwave Ablators: Microwave Ablation Systems 4) By Ultrasound Ablators: High-Intensity Focused Ultrasound (HIFU) Systems 5) By Electric Ablators: Electrosurgical Ablators 6) By Hydrothermal Ablators: Steam Ablation Systems 7) By Cryoablators: Cryoablation Systems

What Is The Driver Of The Ablation Devices Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the ablation device market going forward. The prevalence of chronic diseases is growing due to lifestyle changes, aging populations, and increased longevity. Ablation devices are used in chronic diseases to selectively destroy abnormal tissue, providing minimally invasive treatment options for conditions such as cardiac arrhythmias and certain cancers. For instance, in January 2023, according to research published in Frontiers in Public Health, a Switzerland-based open-access scientific journa, projects that by 2035, 35.66% of the adult population 50 years and older in the United States will have at least one chronic condition, expected to increase to 47.81% by 2050. The proportion of adults with multimorbidity is expected to be 3.659% by 2035, increasing to 5.017% by 2050. Therefore, the increasing prevalence of chronic diseases is driving the growth of the ablation device industry.

Key Players In The Global Ablation Devices Market

Major companies operating in the ablation devices market are Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, AngioDynamics Inc, CONMED Corporation, Olympus Corporation, Smith & Nephew plc, AtriCure Inc, Stryker Corporation, Biotronik SE & Co KG, BTG plc, Terumo Corporation, Varian Medical Systems Inc, Hologic Inc, Accuray Inc, Bard Inc, Elekta AB, Misonix Inc, Japan Lifeline Co Ltd

Global Ablation Devices Market Trends and Insights

Major companies operating in the ablation devices market are focused on developing innovative solutions such as pulsed field ablation systems to improve safety and procedural efficiency in atrial fibrillation treatment. Pulsed field ablation (PFA) uses short, high-voltage electric pulses to create non-thermal, tissue-selective lesions that rapidly ablate myocardium while sparing adjacent structures, reducing collateral thermal injury risk. For instance, on February 2024, Medtronic plc, a US-based medical device company, announced successful first commercial cases using the PulseSelect pulsed field ablation system together with its bi-directional 10F FlexCath Contour sheath, physician feedback highlighted short procedure times, excellent signal quality for pulmonary vein validation, minimal muscle contraction, and the system’s status as the first FDA-approved PFA option available to treat both paroxysmal and persistent atrial fibrillation.

What Are Latest Mergers And Acquisitions In The Ablation Devices Market?

In September 2023, Boston Scientific Corporation, a US-based medical device company, acquired Relievant Medsystems for $850 million. The acquisition aims to expand Boston Scientific's chronic pain portfolio, differentiate its position in advanced interventional chronic pain, and offer physicians a broader selection of evidence-based treatment options that address multiple pain targets. Relievant Medsystems is a US-based medical device company that manufacture ablation devices.

Regional Outlook

North America was the largest region in the ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Ablation Devices Market?

The ablation devices market consists of sales of medical devices such as irreversible electroporation (IRE) ablators, photodynamic therapy (PDT) ablators, high-intensity focused ultrasound (HIFU) ablators, chemical ablators, and mechanical ablators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.